Cyclophosphamide priming reduces intestinal damage in man following high dose melphalan chemotherapy.
A small pre-treatment 'priming' dose of cyclophosphamide will reduce gut damage due to high dose i.v. melphalan in mice and sheep but efforts to demonstrate this effect in man have been hampered by difficulty in the measurement of gut damage. We have evaluated the 51CR EDTA absorption test...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
1987
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001721/ |